TITLE

FDA issues requirements for infusion pump recall

PUB. DATE
September 2010
SOURCE
Hospice Management Advisor;Sep2010, Vol. 15 Issue 9, p104
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses the requirements issued by the U.S. Food and Drug Administration (FDA) on the recall of Baxter Healthcare Corp.'s Colleague Volumetric Infusion Pumps (CVIPs). It says that Baxter is ordered to provide a transition guide and to offer refunds or replacements. It states that supply of batteries, spare parts, and service will continue for the affected pumps of customers who submit a Certificate of Medical Necessity. It adds that the deadline of requirements is on July 14, 2012.
ACCESSION #
54230612

 

Related Articles

  • FDA orders recall of Baxter's infusion pumps.  // Endocrine Today;Jun2010, Vol. 8 Issue 6, p24 

    The article discusses the order of the U.S. Food and Drug Administration (FDA) of the recall and destruction of all Colleague Volumetric Infusion Pumps used in the U.S.

  • Improving patient safety with intelligent infusion devices. Sullivan, Mark // American Journal of Health-System Pharmacy;9/1/2010, Vol. 67 Issue 17, p1415 

    The article reflects on the report by Breland that was published in the 2010 issue of "AJHP" on the implementation of intelligent infusion pumps at a community teaching hospital. He says that the report provides a platform for addressing issues related to the technology's evolution, its...

  • Medtronic recalls infusion pump linked to 14 deaths.  // Medical Device Daily;6/28/2013, Vol. 17 Issue 125, p10 

    The article reports on the announcement by medical device company Medtronic, that its SynchroMed infusion pumps have flaws which led to 14 patient deaths which prompted U.S. regulators to issue a recall for the device.

  • FDA orders Baxter to recall infusion pumps.  // Hospice Management Advisor;Jun2010, Vol. 15 Issue 6, p66 

    The article reports on the letter sent by the U.S. Food and Drug Administration (FDA) to Baxter Healthcare Corp. on April 30, 2010. It says that the letter orders Baxter to recall and ruin all its Colleague Volumetric Infusion Pumps, which is in use in the U.S, give refunds to the customers, and...

  • Baxter faces yet another Class I recall for pumps.  // Medical Technology & Devices Week;7/30/2007, Vol. 5 Issue 31, p5 

    The article reports on the announcement by Baxter Healthcare that the U.S. Food and Drug Administration has classified another recall of its Colleague and Flo-Gard infusion pumps as the serious, Class I variety. The company said the most recent recall is voluntary and pertaining to 534 infusion...

  • Medtronic recall elevated to Class I.  // Medical Device Daily;9/16/2009, Vol. 13 Issue 178, p3 

    The article reports that the Sutureless Connector intrathecal catheters from Medtronic have been elevated to a Class 1 recall by the U.S. Food and Drug Administration (FDA) on September 14, 2009. Products included in the recall are four catheter and revision kit models and the model 8472 IsoMed...

  • FDA warns Medtronic on two products.  // Medical Device Daily;6/29/2009, Vol. 13 Issue 123, p2 

    The article reports on the warning issued by the U.S. Food and Drug Administration (FDA) to Medtronic about its failure to properly report and address flaws in its Synchromed drug pump and MiniMed insulin pump. According to the FDA, it is concerned with the company's failure to recall its...

  • WalkMed among those caught in FDA infusion pump roundup. McCARTY, MARK // Medical Device Daily;11/30/2010, Vol. 14 Issue 231, p1 

    The article reports on the inclusion of WalkMed Infusion in the statement released by the U.S. Food and Drug Administration (FDA) on November 24, 2010 as an update to an announced recall of the Triton pole-mounted infusion pumps. According to the statement, the pump may cause a free-flow...

  • FDA unhappy with time Hospira needs to abandon infusion pumps. McCARTY, MARK // Medical Device Daily;5/22/2013, Vol. 17 Issue 99, p1 

    The article presents response of the U.S. Food and Drug Administration (FDA) to the market withdrawal proposal submitted by drug delivery firm Hospira with regard to its Symbiq and GemStar infusion pump systems. The FDA reportedly expressed concerns about the timeliness of said product recall....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics